Uptake of community antiretroviral group delivery models for persons living with HIV in Arua district, Uganda: A parallel convergent mixed methods study.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2023
Historique:
received: 18 01 2022
accepted: 20 12 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Community antiretroviral groups (CAGs) is one of the innovative and efficient differentiated service delivery models (DSDM) for reaching persons needing human immunodeficiency virus (HIV) treatment in the community. Since DSDM adoption in Uganda, evidence suggests better care outcomes for patients in DSDM compared to counterparts in routine health facility care. However, uptake of CAG models for eligible community groups of persons living with HIV (PLHIV) has been slow in Arua district, Uganda and stakeholders' perceptions regarding its implementation unexplored. The objective of the study was to determine the uptake, barriers and facilitators influencing CAG model implementation in Arua district, Uganda. We conducted a parallel convergent mixed-methods study from March 2020 to December 2020 at Adumi health centre IV and Kuluva hospital in Arua district. We enrolled and extracted data for every fifth virally suppressed participant on antiretroviral therapy (ART) at the two health facilities. Data were analysed using STATA 13.0. Uptake was determined as the proportion of eligible PLHIV that were enrolled into a group. We performed logistic regression to determine factors associated with uptake. We conducted one focus group discussion per facility among healthcare workers involved in the management of PLHIV. We also conducted 7 focus group discussions among PLHIV across the two facilities. Thematic analysis was used to describe the data. A total of 399 PLHIV were eligible for CAG, 61.6% were female, and 44.9% were on dolutegravir (DTG) based regimen. Uptake was 6.8%, 95% CI (4.7-9.7) and was found to be significantly associated with being divorced or separated in a marriage (OR; 0.14, 95%CI; 0.02-0.92, P = 0.014). Members picking drugs in turns, comforting and encouraging others to take the drugs, and health workers advising them to join and stay with other group members were perceived as facilitators to uptake of community antiretroviral group delivery model. Having few and distant eligible members in the local area to form a group, lack of transport among the member to pick the drugs when it's their turn, misunderstandings and lack of confidentiality amongst the members, and lack of partner disclosure were perceived as barriers to uptake of community antiretroviral group delivery model. Uptake of community antiretroviral group delivery model in Arua district is very low. There may be a need to support community antiretroviral group delivery models with income- generating activities, transport facilitation, closer community drug pick-up points and improved partner disclosure support mechanisms among married group members.

Identifiants

pubmed: 36962948
doi: 10.1371/journal.pgph.0000633
pii: PGPH-D-22-00085
pmc: PMC10021482
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000633

Informations de copyright

Copyright: © 2023 Muzeyi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Int AIDS Soc. 2017 Mar 28;20(1):21374
pubmed: 28406273
J Int AIDS Soc. 2013 Jul 19;16:18588
pubmed: 23870277
PLoS One. 2020 Jan 28;15(1):e0228148
pubmed: 31990930
J Int AIDS Soc. 2017 Mar 17;20(1):21386
pubmed: 28364567
BMC Public Health. 2018 Oct 4;18(1):1158
pubmed: 30286746
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
BMJ Open. 2017 Aug 11;7(8):e016800
pubmed: 28801427
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21648
pubmed: 28770597
J Int AIDS Soc. 2016 Jul 20;19(5 Suppl 4):20840
pubmed: 27443270
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21650
pubmed: 28770594
BMC Health Serv Res. 2020 Mar 17;20(1):222
pubmed: 32183796
SAHARA J. 2008 Sep;5(3):136-43
pubmed: 18979047
Trop Med Int Health. 2014 May;19(5):514-21
pubmed: 24898272

Auteurs

Wani Muzeyi (W)

Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Semeere Aggrey (S)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Dennis Kalibbala (D)

Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Thomas Katairo (T)

Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Fred C Semitala (FC)

Department of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Achilles Katamba (A)

Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Irene Ayakaka (I)

Uganda Tuberculosis Implementation Research Consortium, College of Health Sciences, Makerere University, Kampala, Uganda.

Nelson Kalema (N)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Classifications MeSH